EA200200518A1 - Способ и композиция для лечения заболеваний легких - Google Patents

Способ и композиция для лечения заболеваний легких

Info

Publication number
EA200200518A1
EA200200518A1 EA200200518A EA200200518A EA200200518A1 EA 200200518 A1 EA200200518 A1 EA 200200518A1 EA 200200518 A EA200200518 A EA 200200518A EA 200200518 A EA200200518 A EA 200200518A EA 200200518 A1 EA200200518 A1 EA 200200518A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pulmonary diseases
treatment
composition
phosphodiesterase
asthma
Prior art date
Application number
EA200200518A
Other languages
English (en)
Russian (ru)
Inventor
Петер Н. Гудфеллоу
Ричард Нимэн
Теодор Дж. Торфи
Original Assignee
Смитклайн Бичам Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Корпорейшн filed Critical Смитклайн Бичам Корпорейшн
Publication of EA200200518A1 publication Critical patent/EA200200518A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EA200200518A 1999-11-02 2000-11-01 Способ и композиция для лечения заболеваний легких EA200200518A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (fr) 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires

Publications (1)

Publication Number Publication Date
EA200200518A1 true EA200200518A1 (ru) 2002-10-31

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200518A EA200200518A1 (ru) 1999-11-02 2000-11-01 Способ и композиция для лечения заболеваний легких

Country Status (29)

Country Link
EP (1) EP1225866A4 (fr)
JP (1) JP2003513028A (fr)
KR (1) KR20020057988A (fr)
CN (1) CN1387404A (fr)
AP (1) AP2002002496A0 (fr)
AR (1) AR029189A1 (fr)
AU (1) AU1357501A (fr)
BG (1) BG106748A (fr)
BR (1) BR0015270A (fr)
CA (1) CA2388333A1 (fr)
CO (1) CO5261512A1 (fr)
CZ (1) CZ20021512A3 (fr)
DZ (1) DZ3225A1 (fr)
EA (1) EA200200518A1 (fr)
EC (1) ECSP003747A (fr)
HK (1) HK1049107A1 (fr)
HU (1) HUP0203152A3 (fr)
IL (1) IL149367A0 (fr)
MA (1) MA26841A1 (fr)
MX (1) MXPA02004350A (fr)
NO (1) NO20022057L (fr)
OA (1) OA12076A (fr)
PE (1) PE20011005A1 (fr)
PL (1) PL355261A1 (fr)
SK (1) SK7592002A3 (fr)
TR (1) TR200201211T2 (fr)
TW (1) TWI242431B (fr)
WO (1) WO2001032127A2 (fr)
ZA (1) ZA200203435B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210463B1 (pl) * 2001-09-19 2012-01-31 Nycomed Gmbh Zastosowanie kombinacji roflumilastu z diklofenakiem w leczeniu zapalnych chorób stawów
EP1463509A1 (fr) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Inhibiteurs de la phosphodiesterase de type 4 et leurs utilisations
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CA2520577A1 (fr) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Composition pharmaceutique
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (fr) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Traitements prophylactiques ou therapeutiques de maladie chronique de la peau
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
WO2015063669A1 (fr) 2013-10-30 2015-05-07 Wockhardt Limited Compositions pharmaceutiques comprenant une combinaison de roflumilast et d'acébrophylline ou de leurs sels pharmaceutiquement acceptables

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710109T3 (da) * 1993-06-18 2005-01-03 Smithkline Beecham Corp Fremgangsmåde til identifikation af en PDE IV inhibitor
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
NO20022057L (no) 2002-06-27
SK7592002A3 (en) 2002-11-06
BR0015270A (pt) 2002-06-18
PL355261A1 (en) 2004-04-05
BG106748A (en) 2003-02-28
MA26841A1 (fr) 2004-12-20
NO20022057D0 (no) 2002-04-30
PE20011005A1 (es) 2001-09-28
AR029189A1 (es) 2003-06-18
JP2003513028A (ja) 2003-04-08
AU1357501A (en) 2001-05-14
DZ3225A1 (fr) 2001-05-10
CN1387404A (zh) 2002-12-25
CA2388333A1 (fr) 2001-05-10
CZ20021512A3 (cs) 2003-04-16
IL149367A0 (en) 2002-11-10
EP1225866A2 (fr) 2002-07-31
AP2002002496A0 (en) 2002-06-30
WO2001032127A3 (fr) 2001-12-06
KR20020057988A (ko) 2002-07-12
OA12076A (en) 2006-05-04
TR200201211T2 (tr) 2002-08-21
ECSP003747A (es) 2002-05-23
WO2001032127A2 (fr) 2001-05-10
HUP0203152A3 (en) 2004-06-28
HK1049107A1 (zh) 2003-05-02
HUP0203152A2 (hu) 2003-01-28
EP1225866A4 (fr) 2004-04-21
MXPA02004350A (es) 2002-11-07
ZA200203435B (en) 2003-06-25
CO5261512A1 (es) 2003-03-31
TWI242431B (en) 2005-11-01

Similar Documents

Publication Publication Date Title
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
EP1007556A4 (fr) Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
MXPA04000793A (es) Novedoso metodo terapeutico.
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
WO2003000241A3 (fr) Nouvelles compositions de medicament a base d'anticholinergiques, de corticosteroides et d'agents beta-mimetiques
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
DE69324151D1 (de) Inhibitoren des arginin-ketoamid-enzyms
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
WO2002004449A3 (fr) Procedes de traitement d'etats touches par l'activite de transporteuses de plusieurs medicaments
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
EP1251126A3 (fr) Derives de benzenesulfonyle a substitution fluor pour le traitment d'inflammation
EA200500782A1 (ru) Лечение геморрагического шока
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
EA200101214A1 (ru) Замещенные полициклические арил- и гетероарилпиримидиноны, используемые в качестве антикоагулянтов
EA200500244A1 (ru) Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
DE60141274D1 (de) Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
EA200300843A1 (ru) Вирулицидные композиции
EA200100930A1 (ru) Способ лечения хозл